Phosphatidylserine-Containing Liposomes: Potential Pharmacological Interventions Against Inflammatory and Immune Diseases Through the Production of Prostaglandin E2 After Uptake by Myeloid Derived Phagocytes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archivum Immunologiae et Therapiae Experimentalis

• Publication date

  2011-04-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00005-011-0123-4PMID 21479802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of myeloid derived phagocytes by phosphatidylserine-containing liposomes: Possible involvement of prostaglandin E2 and the potential therapeutic application

  2011cited by this paper
• Phosphatidylserine-Containing Liposomes Inhibit the Differentiation of Osteoclasts and Trabecular Bone Loss

  2010influential reference
• The Mechanism of Anti-Inflammatory Effects of Prostaglandin E2 Receptor 4 Activation in Murine Cardiac Transplantation

  2009cited by this paper
• MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

  2009cited by this paper
• Effects of prostaglandin E2 on bone in mice in vivo.

  2009cited by this paper
• Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice

  2008cited by this paper
• Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.

  2008cited by this paper
• Continuous PGE 2 leads to net bone loss while intermittent PGE 2 leads to net bone gain in lumbar vertebral bodies of adult female rats

  2008cited by this paper
• Prostaglandin E2 inhibits tumor necrosis factor-alpha RNA through PKA type I.

  2008cited by this paper
• Activation of PKA and phosphorylation of sodium-dependent vitamin C transporter 2 by prostaglandin E2 promote osteoblast-like differentiation in MC3T3-E1 cells

  2007cited by this paper
• Artificial phosphatidylserine liposome mimics apoptotic cells in inhibiting maturation and immunostimulatory function of murine myeloid dendritic cells in response to 1-chloro-2,4-dinitrobenze in vitro

  2007influential reference
• Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia.

  2006cited by this paper
• Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors*

  2005cited by this paper
• Prostaglandin E2 strongly inhibits human osteoclast formation.

  2005influential reference
• Differential Regulation of Phosphorylation of the cAMP Response Element-Binding Protein after Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2

  2005cited by this paper
• Differential effects of IL‐10 on prostaglandin H synthase‐2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages

  2005cited by this paper
• Phosphatidylserine Regulates the Maturation of Human Dendritic Cells1

  2004cited by this paper
• Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats.

  2004cited by this paper
• Involvement of ERK, a MAP kinase, in the production of TGF-beta by macrophages treated with liposomes composed of phosphatidylserine.

  2004cited by this paper
• Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats

  2004cited by this paper
• Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells.

  2004cited by this paper
• Cyclooxygenase-1-dependent Prostaglandin Synthesis Modulates Tumor Necrosis Factor-α Secretion in Lipopolysaccharide-challenged Murine Resident Peritoneal Macrophages*

  2004influential reference
• Combined TUNEL and TRAP methods suggest that apoptotic bone cells are inside vacuoles of alveolar bone osteoclasts in young rats.

  2003cited by this paper
• Cellular Prostaglandin E2 Production by Membrane-bound Prostaglandin E Synthase-2 via Both Cyclooxygenases-1 and -2*

  2003influential reference
• Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention

  2003cited by this paper
• Genetic regulation of osteoclast development and function

  2003cited by this paper
• Prostaglandin E2 synthesis in human monocyte-derived dendritic cells.

  2003cited by this paper
• Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells

  2003cited by this paper
• Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells.

  2003cited by this paper
• Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes

  2003influential reference
• Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation

  2002cited by this paper
• Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

  2002cited by this paper
• Effects of prostaglandins E1 and E2 on the growth and differentiation of osteoblast-like cells cultured in vitro.

  2002cited by this paper
• The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo

  2002cited by this paper
• Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

  2002cited by this paper
• Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor*

  2002cited by this paper
• Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

  2002cited by this paper
• Expression of Phosphatidylserine Receptor and Down‐Regulation of Pro‐Inflammatory Molecule Production by its Natural Ligand in Rat Microglial Cultures

  2002cited by this paper
• Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFalpha-formation in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells.

  2002cited by this paper
• Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes.

  2001influential reference
• Effects of prostaglandin E2 and nitric oxide inhibitors on the expression of interleukin-10, interleukin-12 and MHC class-II molecules in Mycobacterium microti-infected and interferon-gamma-treated mouse peritoneal macrophages.

  2001cited by this paper
• Apoptotic bone cells may be engulfed by osteoclasts during alveolar bone resorption in young rats.

  2001cited by this paper
• Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells

  2001cited by this paper
• Bifurcation of osteoclasts and dendritic cells from common progenitors.

  2001cited by this paper
• RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.

  2000cited by this paper
• Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

  2000cited by this paper
• The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells

  2000cited by this paper
• Cellular components that functionally interact with signaling phospholipase A(2)s.

  2000cited by this paper
• 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors.

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Selective modulation of BV-2 microglial activation by prostaglandin E(2). Differential effects on endotoxin-stimulated cytokine induction.

  1999cited by this paper
• Opposite effects of interferon‐γ and prostaglandin E2 on tumor necrosis factor and interleukin‐10 production in microglia: A regulatory loop controlling microglia pro‐ and anti‐inflammatory activities

  1999influential reference
• Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

  1998cited by this paper
• Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Effects of prostaglandins on human hematopoietic osteoclast precursors.

  1997cited by this paper
• Effects of Prostaglandins on Human Hematopoietic Osteoclast Precursors.

  1997cited by this paper
• Microglia: a sensor for pathological events in the CNS.

  1996cited by this paper
• PGE2 and the immune response. A central role for prostaglandin E2 in downregulating the inflammatory immune response.

  1995cited by this paper
• PGE2 and the immune response

  1995cited by this paper
• Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells

  1994cited by this paper
• Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2.

  1992cited by this paper
• Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.

  1990cited by this paper
• Macrophages and microglia in the nervous system.

  1988influential reference
• Prostaglandin E2 stimulates collagen and non-collagen protein synthesis and prolyl hydroxylase activity in osteoblastic clone MC3T3-E1 cells.

  1985cited by this paper
• The Effect of Prostaglandin

  1972cited by this paper
• Research Paper Mediators of Inflammation, 8, 295–303 (1999)

  year unknowncited by this paper

• Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2)

  2025cites this paper
• Therapeutic liposomes synergize with active molecules to enhance targeted therapy

  2025cites this paper
• The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells

  2023cites this paper
• Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance

  2023cites this paper
• Liquid chromatography-mass spectrometry method for discovering the metabolic markers to reveal the potential therapeutic effects of naringin on osteoporosis.

  2022cites this paper
• Milk Polar Lipids Supplementation to Obese Rats During Pregnancy and Lactation Benefited Skeletal Outcomes of Male Offspring.

  2021cites this paper
• Strategies and Tools for Studying Microglial-Mediated Synapse Elimination and Refinement

  2021cites this paper
• Induction of bone repair in rat calvarial defects using a combination of hydroxyapatite with phosphatidylserine liposomes.

  2019cites this paper
• Phosphatidylcholine attenuates LPS-induced immunomodulatory effect through slc26a3/DRA-mediated signaling in primary chicken intestinal epithelial cells

  2018cites this paper
• Manufacture and characterization of anti-inflammatory liposomes from jumbo flying squid (Dosidicus gigas) skin phospholipid extraction.

  2018cites this paper
• Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation

  2018cites this paper
• Phospholipid secretions of organ cultured ciliary body

  2018cites this paper
• Highlights in Endocytosis of Nanostructured Systems.

  2017cites this paper
• Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology

  2017cites this paper
• Deadly tricks to combat atherosclerosis.

  2015cites this paper
• Drug Carriers: Not an Innocent Delivery Man

  2015cites this paper
• What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?

  2015cites this paper
• HCMV Reprogramming of Infected Monocyte Survival and Differentiation: A Goldilocks Phenomenon

  2014cites this paper
• HIV-1: identification of a pathway for virus release and development of a new nanotechnological strategy to counteract the infection

  2014cites this paper
• Possible involvement of aiPLA2 in the phosphatidylserine-containing liposomes induced production of PGE2 and PGD2 in microglia.

  2013influential citation
• MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease.

  2013cites this paper
• A new liposome-based gene delivery system targeting lung epithelial cells using endothelin antagonist.

  2012cites this paper
• Exosome mimetics: a novel class of drug delivery systems

  2012cites this paper
• Dissertação para obtenção do Grau de Mestre em Genética Molecular e Biomedicina

  2011cites this paper
• Microglial clearance function: dependence on phenotypes

  2011cites this paper